BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8887671)

  • 1. Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells.
    Huang C; Ma WY; Dong Z
    Mol Cell Biol; 1996 Nov; 16(11):6427-35. PubMed ID: 8887671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein 1 activation.
    Huang C; Schmid PC; Ma WY; Schmid HH; Dong Z
    J Biol Chem; 1997 Feb; 272(7):4187-94. PubMed ID: 9020132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer.
    Dong Z; Huang C; Ma WY
    Anticancer Res; 1999; 19(5A):3743-7. PubMed ID: 10625951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin.
    Suga J; Yoshimasa Y; Yamada K; Yamamoto Y; Inoue G; Okamoto M; Hayashi T; Shigemoto M; Kosaki A; Kuzuya H; Nakao K
    Diabetes; 1997 May; 46(5):735-41. PubMed ID: 9133538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells.
    Liu G; Bibus DM; Bode AM; Ma WY; Holman RT; Dong Z
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7510-5. PubMed ID: 11416221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts.
    Takuwa N; Fukui Y; Takuwa Y
    Mol Cell Biol; 1999 Feb; 19(2):1346-58. PubMed ID: 9891068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblasts.
    Yamane K; Ihn H; Tamaki K
    Arthritis Rheum; 2003 Jun; 48(6):1652-66. PubMed ID: 12794834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38 Mitogen-activated protein kinase regulation of JB6 Cl41 cell transformation promoted by epidermal growth factor.
    He Z; Cho YY; Liu G; Ma WY; Bode AM; Dong Z
    J Biol Chem; 2003 Jul; 278(29):26435-42. PubMed ID: 12748197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol 3-kinase mediates the inhibitory effect of epidermal growth factor on calcium-dependent chloride secretion.
    Uribe JM; Keely SJ; Traynor-Kaplan AE; Barrett KE
    J Biol Chem; 1996 Oct; 271(43):26588-95. PubMed ID: 8900131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-beta in rat hepatocytes. role of phosphatidylinositol 3-kinase-induced AP-1 activation.
    Peron P; Rahmani M; Zagar Y; Durand-Schneider AM; Lardeux B; Bernuau D
    J Biol Chem; 2001 Mar; 276(13):10524-31. PubMed ID: 11134003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
    Ma C; Wang J; Gao Y; Gao TW; Chen G; Bower KA; Odetallah M; Ding M; Ke Z; Luo J
    Cancer Res; 2007 Aug; 67(16):7756-64. PubMed ID: 17699780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF-induced activation of 70-kDa S6 kinase in CHO cells expressing human EGF receptors.
    Kido Y; Okabayashi Y; Okutani T; Sugimoto Y; Sakaguchi K; Kasuga M
    Biochem Biophys Res Commun; 1995 Apr; 209(1):131-8. PubMed ID: 7726827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor stimulation of phosphatidylinositol 3-kinase during wound closure in rabbit corneal epithelial cells.
    Zhang Y; Akhtar RA
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1139-48. PubMed ID: 9152233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells.
    Huang C; Ma WY; Young MR; Colburn N; Dong Z
    Proc Natl Acad Sci U S A; 1998 Jan; 95(1):156-61. PubMed ID: 9419345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brush border phosphatidylinositol 3-kinase mediates epidermal growth factor stimulation of intestinal NaCl absorption and Na+/H+ exchange.
    Khurana S; Nath SK; Levine SA; Bowser JM; Tse CM; Cohen ME; Donowitz M
    J Biol Chem; 1996 Apr; 271(17):9919-27. PubMed ID: 8626628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol 3-kinase mediates mitogen-induced human airway smooth muscle cell proliferation.
    Krymskaya VP; Penn RB; Orsini MJ; Scott PH; Plevin RJ; Walker TR; Eszterhas AJ; Amrani Y; Chilvers ER; Panettieri RA
    Am J Physiol; 1999 Jul; 277(1):L65-78. PubMed ID: 10409232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation.
    King WG; Mattaliano MD; Chan TO; Tsichlis PN; Brugge JS
    Mol Cell Biol; 1997 Aug; 17(8):4406-18. PubMed ID: 9234699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
    Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
    Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MG-63 cell proliferation and PDGF-stimulated cellular processes by inhibitors of phosphatidylinositol 3-kinase.
    Thomas JE; Venugopalan M; Galvin R; Wang Y; Bokoch GM; Vlahos CJ
    J Cell Biochem; 1997 Feb; 64(2):182-95. PubMed ID: 9027579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
    Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
    Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.